423165-33-7

Usage

Uses

Used in Pharmaceutical Industry:
2-BROMO-5-NITROETHOXYBENZENE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and improve existing ones. Its unique chemical structure allows it to be a building block in the creation of molecules with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-BROMO-5-NITROETHOXYBENZENE is utilized as an intermediate in the production of pesticides and other crop protection agents. Its role in this industry is vital for enhancing crop yields and ensuring food security by protecting crops from pests and diseases.
Used in Specialty Chemicals Industry:
2-BROMO-5-NITROETHOXYBENZENE is also employed in the manufacturing of specialty chemicals, where its unique properties are leveraged to create high-value products for specific applications. These applications can range from dyes and pigments to advanced materials with tailored properties.
Safety and Environmental Considerations:
It is important to handle 2-BROMO-5-NITROETHOXYBENZENE with care due to its toxic nature if ingested and its potential to cause irritation to the skin, eyes, and respiratory system. Additionally, it may have harmful effects on aquatic organisms, necessitating proper disposal and containment measures to minimize environmental impact.

InChI:InChI=1/C8H8BrNO3/c1-2-13-8-5-6(10(11)12)3-4-7(8)9/h3-5H,2H2,1H3

Upstream product

• 52427-05-1 2-bromo-5-nitrophenol 
• 75-03-6 ethyl iodide 

Downstream Products

• 1024955-77-8 4-(2-ethoxy-4-nitrophenyl)pyridine 
• 125756-95-8 4-bromo-3-ethoxy aniline 
• 1352619-74-9 N-[4-(2-{[2-ethoxy-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]-2-(4-fluorophenyl)acetamide 
• 1352620-17-7 4-(2-{[2-ethoxy-4-(2-oxo-1,3-oxazolidin-3-yl)phenyl]amino}[1,2,4]triazolo-[1,5-a]pyridin-6-yl)-N-(4-fluorobenzyl)benzamide 
• 1403329-94-1 N-(cyclopropylmethyl)-4-{2-[(2-ethoxy-4-nitrophenyl)amino][1,2,4]-triazolo[1,5-a]pyridin-6-yl}benzamide 
• 1403329-95-2 4-{2-[(4-amino-2-ethoxyphenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}-N-(cyclopropylmethyl)benzamide 
• 1024955-56-3 4-(2-ethoxy-4-nitrophenyl)-1-methylpyridinium iodide 
• 1025216-24-3 C₁₄H₂₂N₂O 
• 1024953-89-6 4-[(2,4-difluorophenyl)amino]-7-ethoxy-6-(1-methylpiperidin-4-yl)quinoline-3-carboxamide 
• 1024954-75-3 ethyl 4-[(2,4-difluorophenyl)amino]-7-ethoxy-6-(1-methylpiperidin-4-yl)quinoline-3-carboxylate 
• 1024954-81-1 ethyl 4-[(2,3-dichlorophenyl)amino]-7-ethoxy-6-(1-methylpiperidin-4-yl)quinoline-3-carboxylate 
• 1024953-96-5 4-[(2,3-dichlorophenyl)amino]-7-ethoxy-6-(1-methylpiperidin-4-yl)quinoline-3-carboxamide 

Relevant academic research and scientific papers

LACTAMS AS INHIBITORS OF ROCK

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.